PMC:7795856 / 3117-5187
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
113 | 34-37 | Gene | denotes | Tα1 | Gene:134864 |
114 | 372-375 | Gene | denotes | Tα1 | Gene:134864 |
115 | 583-586 | Gene | denotes | Tα1 | Gene:134864 |
116 | 911-914 | Gene | denotes | Tα1 | Gene:134864 |
117 | 965-971 | Gene | denotes | CTLA-4 | Gene:1493 |
118 | 1044-1047 | Gene | denotes | Tα1 | Gene:20539 |
119 | 1115-1121 | Gene | denotes | CTLA-4 | Gene:12477 |
120 | 1456-1459 | Gene | denotes | Tα1 | Gene:20539 |
121 | 1617-1620 | Gene | denotes | Tα1 | Gene:20539 |
122 | 1747-1750 | Gene | denotes | Tα1 | Gene:134864 |
123 | 1801-1807 | Gene | denotes | hIFN-α | Gene:3439 |
124 | 1937-1940 | Gene | denotes | Tα1 | Gene:134864 |
125 | 879-887 | Species | denotes | patients | Tax:9606 |
126 | 1094-1100 | Species | denotes | murine | Tax:10090 |
127 | 1781-1786 | Species | denotes | human | Tax:9606 |
128 | 1914-1922 | Species | denotes | patients | Tax:9606 |
129 | 223-226 | Species | denotes | HBV | Tax:10407 |
130 | 250-253 | Species | denotes | HCV | Tax:11103 |
131 | 951-961 | Chemical | denotes | ipilimumab | MESH:D000074324 |
132 | 1003-1013 | Chemical | denotes | ipilimumab | MESH:D000074324 |
133 | 202-221 | Disease | denotes | chronic hepatitis B | MESH:D019694 |
134 | 229-248 | Disease | denotes | chronic hepatitis C | MESH:D019698 |
135 | 437-443 | Disease | denotes | cancer | MESH:D009369 |
136 | 608-619 | Disease | denotes | cold tumors | MESH:D000067390 |
137 | 710-716 | Disease | denotes | tumors | MESH:D009369 |
138 | 870-878 | Disease | denotes | melanoma | MESH:D008545 |
139 | 1069-1088 | Disease | denotes | intestinal toxicity | MESH:D007410 |
140 | 1130-1137 | Disease | denotes | colitis | MESH:D003092 |
141 | 1268-1283 | Disease | denotes | cystic fibrosis | MESH:D003550 |
142 | 1290-1308 | Disease | denotes | multiple sclerosis | MESH:D009103 |
143 | 1319-1325 | Disease | denotes | sepsis | MESH:D018805 |
144 | 1437-1445 | Disease | denotes | COVID-19 | MESH:C000657245 |
145 | 1524-1532 | Disease | denotes | COVID-19 | MESH:C000657245 |
146 | 1576-1582 | Disease | denotes | sepsis | MESH:D018805 |
147 | 1702-1710 | Disease | denotes | COVID-19 | MESH:C000657245 |
148 | 1711-1720 | Disease | denotes | infection | MESH:D007239 |
149 | 1967-1976 | Disease | denotes | mortality | MESH:D003643 |
150 | 1987-1995 | Disease | denotes | COVID-19 | MESH:C000657245 |
151 | 2014-2029 | Disease | denotes | lymphocytopenia | MESH:D008231 |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T7 | 202-219 | Phenotype | denotes | chronic hepatitis | http://purl.obolibrary.org/obo/HP_0200123 |
T8 | 229-246 | Phenotype | denotes | chronic hepatitis | http://purl.obolibrary.org/obo/HP_0200123 |
T9 | 437-443 | Phenotype | denotes | cancer | http://purl.obolibrary.org/obo/HP_0002664 |
T10 | 870-878 | Phenotype | denotes | melanoma | http://purl.obolibrary.org/obo/HP_0002861 |
T11 | 1130-1137 | Phenotype | denotes | colitis | http://purl.obolibrary.org/obo/HP_0002583 |
T12 | 1319-1325 | Phenotype | denotes | sepsis | http://purl.obolibrary.org/obo/HP_0100806 |
T13 | 1576-1582 | Phenotype | denotes | sepsis | http://purl.obolibrary.org/obo/HP_0100806 |
T14 | 2014-2029 | Phenotype | denotes | lymphocytopenia | http://purl.obolibrary.org/obo/HP_0001888 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T22 | 0-148 | Sentence | denotes | In fact, a chemically synthesized Tα1 peptide drug has been marketed for more than 20 years under the trade name Zadaxin™ in more than 30 countries. |
T23 | 149-351 | Sentence | denotes | Zadaxin™ is clinically approved for the treatment of chronic hepatitis B (HBV), chronic hepatitis C (HCV), as a vaccine adjuvant, and as adjuvant therapy for chemotherapy-induced immune suppression [7]. |
T24 | 352-543 | Sentence | denotes | Of note, the use of Tα1 has recently undergone reassessment in the context of modern cancer immunotherapies, as there is indication that this peptide may support immune checkpoint inhibition. |
T25 | 544-761 | Sentence | denotes | Preclinical data provide evidence that Tα1 transforms so called cold tumors, which poorly respond to immune checkpoint inhibitors, into highly lymphocyte-infiltrated tumors and, thus, boosts therapeutic efficacy [15]. |
T26 | 762-1033 | Sentence | denotes | Indeed, a retrospective study evaluating clinical phase II data reported an increase in overall survival of melanoma patients receiving sequentially Tα1 and the immune checkpoint inhibitor ipilimumab, a CTLA-4-blocking antibody, compared to ipilimumab therapy alone [16]. |
T27 | 1034-1225 | Sentence | denotes | Moreover, Tα1 was shown to prevent intestinal toxicity in a murine model of anti-CTLA-4-induced colitis, hence contributing to an improved safety profile of immune checkpoint inhibitors [17]. |
T28 | 1226-1402 | Sentence | denotes | Beyond that, emerging indications such as cystic fibrosis [18], multiple sclerosis [19], and sepsis [20] further emphasize the huge potential of this small therapeutic peptide. |
T29 | 1403-1502 | Sentence | denotes | Finally, with the outbreak of the COVID-19 pandemic, Tα1 recently gained new attention in virology. |
T30 | 1503-1636 | Sentence | denotes | Clinical symptoms of COVID-19 to some extent resemble a pathogen-induced sepsis, which justifies immunomodulatory Tα1 treatment [21]. |
T31 | 1637-1852 | Sentence | denotes | Along these lines, Chinese medical staff members at high risk of COVID-19 infection already received a weekly Tα1 injection in combination with human interferon 1 (hIFN-α) nasal drops as a prophylactic measure [22]. |
T32 | 1853-2070 | Sentence | denotes | Furthermore, a recent retrospective study in treated Chinese patients revealed that Tα1 significantly reduced the mortality of severe COVID-19 by restoration of lymphocytopenia and reversion of exhausted T cells [23]. |